2017

  • Schultheiss CS, Laggei S, Czepukojc B, Hussein UK, List M, Barghash A, Tierling S, Hosseini K, Golob-Schwarzl N, Pokorny J, Hachenthal N, Schulz M, Helms V, Walter J, Zimmer V, Lammert F, Bohle RM, Dandolo L, Haybaeck J, Kiemer AK, Kessler SM. 2017. The long non-conding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma. Cell Stress 1:37-57
  • Kessler SM, Lederer E, Laggai S, Golob-Schwarzl N, Hosseini K, Petzold J, Schweiger C, Reihs R, Keil M, Hoffmann J, Christian Mayr, Kiesslich T, Pilcher M, Kim KS, Rhee H, Park YN, Lax S, Obrist P, Kiemer AK, Haybaeck J. 2017. IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. Oncotarget 8:89736-89745
  • Seif M, Hoppstädter J, Breinig F, Kiemer AK. 2017. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm 117:1-13
  • Dembek A, Laggai S, Kessler SM, Czepukojc B, Simon Y, Kiemer AK, Hoppstädter J. 2017. Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation.  Immunobiology 222:786-796
  • Philippi F, Rauber D, Zapp J, Hempelmann R. 2017. Transport properties and ionicity of phosphonium ionic liquids. Phys Chem Chem Phys 19:23015-23023
  • Neunzig J, Milhim M, Schiffer L, Zapp J, Sanchez-Guijo A, Hartmann MF, Wudy SA, Bernhardt R. 2017. The steroid metabolite 16(ß)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1. Steroid Biochem Mol Biol 167:182-191
  • Abdulmughni A, Jozwik IK, Putkaradze N, Brill E, Zapp J, Thunnissen, Andy-Mark WH, Hannemann F, Bernhardt R. 2017. Characterization of cytochrome P450 CYP109E1 from Bacillus megaterium as a novel vitamin D3 hydroxylase. Biotechnol 243:38-47
  • Putkaradze N, Kiss FM, Schmitz D, Zapp J, Hutter MC, Bernhardt R. 2017. Biotransformation of prednisone and dexamethasone by cytochrome P450 based systems - Identification of new potential drug candidates. J Biotechnol 242:101-110